Mouse model studies have shown that obese mice with leukemia have a significantly improved prognosis and a significant increase in survival rate after changing their diet from high-fat diet to low-fat diet before chemotherapy.

A new study by the University of California, Los Angeles shows that dietary intervention can help kill cancer cells. Mouse model studies have shown that obese mice with leukemia have a significantly improved prognosis and a significant increase in survival after changing their diet from a high-fat diet to a low-fat diet before chemotherapy.

Acute lymphocytic leukemia is the most common form of childhood cancer. Studies have found that one-third of children with this type of cancer are overweight or obese when they are diagnosed with cancer. Their chemotherapy is relatively ineffective, and the recurrence rate after chemotherapy is also higher than that of normal-weight children. 50% higher. Obviously, obesity is not conducive to the treatment of leukemia, but can this condition be improved by losing weight? Is it useful to let your child diet? These problems have not been confirmed by scientific research.

Ateam led by Dr. Steven Mitterman of the University of California, Los Angeles, tested the mice. They used vincristine, an antineoplastic agent, to treat obese and non-obese mice with leukemia and adjusted the diet of the mice. It was found that if the diet of obese mice was changed from high fat to low-fat diet before starting chemotherapy, the prognosis of the mice was significantly improved and the survival rate was also significantly improved. The survival rate of mice in the low-fat diet group was 5 times that in the high-fat diet group.

Mitterman pointed out that their findings suggest that dietary interventions can help kill cancer cells in leukemia patients, and simple changes in some eating habits may increase patient survival. This finding is exciting. At present, the research team has begun human trials to test the effect of dietary intervention on chemotherapy in children with leukemia.